Global Neurology Digital Therapeutics Market Growth (Status and Outlook) 2023-2029
Description
Global Neurology Digital Therapeutics Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “Neurology Digital Therapeutics Industry Forecast” looks at past sales and reviews total world Neurology Digital Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurology Digital Therapeutics sales for 2023 through 2029. With Neurology Digital Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurology Digital Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Neurology Digital Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurology Digital Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurology Digital Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurology Digital Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurology Digital Therapeutics.
The global Neurology Digital Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurology Digital Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurology Digital Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurology Digital Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurology Digital Therapeutics players cover Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs and Mango Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurology Digital Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Software
Devices
Segmentation by application
Hospital
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics
Please note: The report will take approximately 2 business days to prepare and deliver.
LPI (LP Information)' newest research report, the “Neurology Digital Therapeutics Industry Forecast” looks at past sales and reviews total world Neurology Digital Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurology Digital Therapeutics sales for 2023 through 2029. With Neurology Digital Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurology Digital Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Neurology Digital Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurology Digital Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurology Digital Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurology Digital Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurology Digital Therapeutics.
The global Neurology Digital Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurology Digital Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurology Digital Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurology Digital Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurology Digital Therapeutics players cover Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs and Mango Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurology Digital Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Software
Devices
Segmentation by application
Hospital
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
102 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Neurology Digital Therapeutics Market Size 2018-2029
- 2.1.2 Neurology Digital Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Neurology Digital Therapeutics Segment by Type
- 2.2.1 Software
- 2.2.2 Devices
- 2.3 Neurology Digital Therapeutics Market Size by Type
- 2.3.1 Neurology Digital Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Neurology Digital Therapeutics Market Size Market Share by Type (2018-2023)
- 2.4 Neurology Digital Therapeutics Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Neurology Digital Therapeutics Market Size by Application
- 2.5.1 Neurology Digital Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Neurology Digital Therapeutics Market Size Market Share by Application (2018-2023)
- 3 Neurology Digital Therapeutics Market Size by Player
- 3.1 Neurology Digital Therapeutics Market Size Market Share by Players
- 3.1.1 Global Neurology Digital Therapeutics Revenue by Players (2018-2023)
- 3.1.2 Global Neurology Digital Therapeutics Revenue Market Share by Players (2018-2023)
- 3.2 Global Neurology Digital Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Neurology Digital Therapeutics by Regions
- 4.1 Neurology Digital Therapeutics Market Size by Regions (2018-2023)
- 4.2 Americas Neurology Digital Therapeutics Market Size Growth (2018-2023)
- 4.3 APAC Neurology Digital Therapeutics Market Size Growth (2018-2023)
- 4.4 Europe Neurology Digital Therapeutics Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Neurology Digital Therapeutics Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Neurology Digital Therapeutics Market Size by Country (2018-2023)
- 5.2 Americas Neurology Digital Therapeutics Market Size by Type (2018-2023)
- 5.3 Americas Neurology Digital Therapeutics Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Neurology Digital Therapeutics Market Size by Region (2018-2023)
- 6.2 APAC Neurology Digital Therapeutics Market Size by Type (2018-2023)
- 6.3 APAC Neurology Digital Therapeutics Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Neurology Digital Therapeutics by Country (2018-2023)
- 7.2 Europe Neurology Digital Therapeutics Market Size by Type (2018-2023)
- 7.3 Europe Neurology Digital Therapeutics Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Neurology Digital Therapeutics by Region (2018-2023)
- 8.2 Middle East & Africa Neurology Digital Therapeutics Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Neurology Digital Therapeutics Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Neurology Digital Therapeutics Market Forecast
- 10.1 Global Neurology Digital Therapeutics Forecast by Regions (2024-2029)
- 10.1.1 Global Neurology Digital Therapeutics Forecast by Regions (2024-2029)
- 10.1.2 Americas Neurology Digital Therapeutics Forecast
- 10.1.3 APAC Neurology Digital Therapeutics Forecast
- 10.1.4 Europe Neurology Digital Therapeutics Forecast
- 10.1.5 Middle East & Africa Neurology Digital Therapeutics Forecast
- 10.2 Americas Neurology Digital Therapeutics Forecast by Country (2024-2029)
- 10.2.1 United States Neurology Digital Therapeutics Market Forecast
- 10.2.2 Canada Neurology Digital Therapeutics Market Forecast
- 10.2.3 Mexico Neurology Digital Therapeutics Market Forecast
- 10.2.4 Brazil Neurology Digital Therapeutics Market Forecast
- 10.3 APAC Neurology Digital Therapeutics Forecast by Region (2024-2029)
- 10.3.1 China Neurology Digital Therapeutics Market Forecast
- 10.3.2 Japan Neurology Digital Therapeutics Market Forecast
- 10.3.3 Korea Neurology Digital Therapeutics Market Forecast
- 10.3.4 Southeast Asia Neurology Digital Therapeutics Market Forecast
- 10.3.5 India Neurology Digital Therapeutics Market Forecast
- 10.3.6 Australia Neurology Digital Therapeutics Market Forecast
- 10.4 Europe Neurology Digital Therapeutics Forecast by Country (2024-2029)
- 10.4.1 Germany Neurology Digital Therapeutics Market Forecast
- 10.4.2 France Neurology Digital Therapeutics Market Forecast
- 10.4.3 UK Neurology Digital Therapeutics Market Forecast
- 10.4.4 Italy Neurology Digital Therapeutics Market Forecast
- 10.4.5 Russia Neurology Digital Therapeutics Market Forecast
- 10.5 Middle East & Africa Neurology Digital Therapeutics Forecast by Region (2024-2029)
- 10.5.1 Egypt Neurology Digital Therapeutics Market Forecast
- 10.5.2 South Africa Neurology Digital Therapeutics Market Forecast
- 10.5.3 Israel Neurology Digital Therapeutics Market Forecast
- 10.5.4 Turkey Neurology Digital Therapeutics Market Forecast
- 10.5.5 GCC Countries Neurology Digital Therapeutics Market Forecast
- 10.6 Global Neurology Digital Therapeutics Forecast by Type (2024-2029)
- 10.7 Global Neurology Digital Therapeutics Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 Livongo Health
- 11.1.1 Livongo Health Company Information
- 11.1.2 Livongo Health Neurology Digital Therapeutics Product Offered
- 11.1.3 Livongo Health Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Livongo Health Main Business Overview
- 11.1.5 Livongo Health Latest Developments
- 11.2 Noom
- 11.2.1 Noom Company Information
- 11.2.2 Noom Neurology Digital Therapeutics Product Offered
- 11.2.3 Noom Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Noom Main Business Overview
- 11.2.5 Noom Latest Developments
- 11.3 Omada Health
- 11.3.1 Omada Health Company Information
- 11.3.2 Omada Health Neurology Digital Therapeutics Product Offered
- 11.3.3 Omada Health Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Omada Health Main Business Overview
- 11.3.5 Omada Health Latest Developments
- 11.4 Pear Therapeutics
- 11.4.1 Pear Therapeutics Company Information
- 11.4.2 Pear Therapeutics Neurology Digital Therapeutics Product Offered
- 11.4.3 Pear Therapeutics Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Pear Therapeutics Main Business Overview
- 11.4.5 Pear Therapeutics Latest Developments
- 11.5 WellDoc
- 11.5.1 WellDoc Company Information
- 11.5.2 WellDoc Neurology Digital Therapeutics Product Offered
- 11.5.3 WellDoc Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 WellDoc Main Business Overview
- 11.5.5 WellDoc Latest Developments
- 11.6 Proteus Digital Health
- 11.6.1 Proteus Digital Health Company Information
- 11.6.2 Proteus Digital Health Neurology Digital Therapeutics Product Offered
- 11.6.3 Proteus Digital Health Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Proteus Digital Health Main Business Overview
- 11.6.5 Proteus Digital Health Latest Developments
- 11.7 Propeller Health
- 11.7.1 Propeller Health Company Information
- 11.7.2 Propeller Health Neurology Digital Therapeutics Product Offered
- 11.7.3 Propeller Health Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Propeller Health Main Business Overview
- 11.7.5 Propeller Health Latest Developments
- 11.8 Akili Interactive Labs
- 11.8.1 Akili Interactive Labs Company Information
- 11.8.2 Akili Interactive Labs Neurology Digital Therapeutics Product Offered
- 11.8.3 Akili Interactive Labs Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Akili Interactive Labs Main Business Overview
- 11.8.5 Akili Interactive Labs Latest Developments
- 11.9 Mango Health
- 11.9.1 Mango Health Company Information
- 11.9.2 Mango Health Neurology Digital Therapeutics Product Offered
- 11.9.3 Mango Health Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Mango Health Main Business Overview
- 11.9.5 Mango Health Latest Developments
- 11.10 Better Therapeutics
- 11.10.1 Better Therapeutics Company Information
- 11.10.2 Better Therapeutics Neurology Digital Therapeutics Product Offered
- 11.10.3 Better Therapeutics Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Better Therapeutics Main Business Overview
- 11.10.5 Better Therapeutics Latest Developments
- 11.11 Happify
- 11.11.1 Happify Company Information
- 11.11.2 Happify Neurology Digital Therapeutics Product Offered
- 11.11.3 Happify Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Happify Main Business Overview
- 11.11.5 Happify Latest Developments
- 11.12 Kaia Health
- 11.12.1 Kaia Health Company Information
- 11.12.2 Kaia Health Neurology Digital Therapeutics Product Offered
- 11.12.3 Kaia Health Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Kaia Health Main Business Overview
- 11.12.5 Kaia Health Latest Developments
- 11.13 Click Therapeutics
- 11.13.1 Click Therapeutics Company Information
- 11.13.2 Click Therapeutics Neurology Digital Therapeutics Product Offered
- 11.13.3 Click Therapeutics Neurology Digital Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 Click Therapeutics Main Business Overview
- 11.13.5 Click Therapeutics Latest Developments
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
